National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Pain (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 10/29/2008
Dosing Recommendations for Acetaminophen and NSAIDs

Drug  Usual Dose for Adults and Children ≥50 kg Body Weight  Usual Dose for Adults and Children1 <50 kg Body Weight 
Orally Administered Acetaminophen and Over-the-counter NSAIDs
acetaminophen2 650 mg q 4 h 10–15 mg/kg q 4 h
975 mg q 6 h 15–20 mg/kg q 4 h (rectal)
aspirin3 650 mg q 4 h 10–15 mg/kg q 4 h
975 mg q 6 h 15–20 mg/kg q 4 h (rectal)
ibuprofen (Motrin, Advil) 400–600 mg q 6 h 5–10 mg/kg q 4–6 h
magnesium salicylate (Doan’s, Magan, Mobidin, others) 650 mg q 4 h
naproxen (Naprosyn, Aleve) 250–275 mg q 6–8 h 5 mg/kg q 8 h
naproxen sodium (Anaprox) 275 mg q 6–8 h
Prescription NSAIDs
carprofen (Rimadyl) 100 mg tid
choline magnesium trisalicylate4 (Trilisate) 1,000–1,500 mg q 6–8 h 25 mg/kg q 6–8 h
choline salicylate4 (Arthropan) 870 mg q 3–4 h
diflunisal5 (Dolobid) 500 mg q 12 h
etodolac (Lodine) 200–400 mg q 6–8 h
fenoprofen calcium (Nalfon) 300–600 mg q 6 h
ketoprofen (Orudis) 25–60 mg q 6–8 h
ketorolac tromethamine6 (Toradol) 10 mg q 4–6 h to a maximum of 40 mg/day
IV administration should not exceed 5 days
meclofenamate sodium7 (Meclomen) 50–100 mg q 6 h
mefenamic acid (Ponstel) 250 mg q 6 h
sodium salicylate (Anacin, Bufferin) 325–650 mg q 3–4 h
Parenteral NSAIDs
ketorolac tromethamine6,8 (Toradol) 60 mg initially, then 30 mg q 6 h
IV administration should not exceed 5 days

IV = intravenous; q = every.
1. Acetaminophen and NSAID dosages for adults weighing less than 50 kg should be adjusted for weight.
2. Acetaminophen lacks the peripheral anti-inflammatory and antiplatelet activities of the other NSAIDs.
3. The standard against which other NSAIDs are compared. May inhibit platelet aggregation for longer than 1 week and may cause bleeding. Aspirin is not recommended for pain in children.
4. May have minimal antiplatelet activity.
5. Administration with antacids may decrease absorption.
6. Use limited to 5 days or fewer.
7. Coombs-positive autoimmune hemolytic anemia has been associated with prolonged use.
8. Has the same gastrointestinal toxic effects as oral NSAIDs.
 [Note: Only the above NSAIDs have FDA approval for use as simple analgesics, but clinical experience has been gained with other drugs as well.]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov